Leadership in health care private equity since 1986

The Latest News

March 04, 2014

Synageva BioPharma™ Issued U.S. Patent for Treatment of LAL Deficiency>

Synageva BioPharma Corp. (Synageva) (NASDAQ:GEVA), announced that the U.S. Patent and Trademark Office today issued U.S. Patent No. 8,663,631 covering methods of treating lysosomal acid lipase deficiency (LAL Deficiency). This patent provides protection until 2031, not including any patent term extension. The patent complements Synageva’s existing and planned global patent portfolio covering its LAL Deficiency program, which includes intellectual 
property directed to composition of matter, methods of use, and manufacturing. 
February 26, 2014

SafeOp Surgical Receives FDA Clearance For EPAD™ Neuromonitoring Device>

SafeOp Surgical, Inc. (“SafeOp”) has received FDA clearance to market its Evoked Potential Assessment Device (EPAD™). The device is portable and intended for use in monitoring neurological status by recording somatosensory evoked potentials (SSEPs) or assessing the neuromuscular junction (NMJ). 

February 04, 2014

LivHOME Appoints Richard Slager to Board of Directors>

LivHOME, Inc., one of the nation’s largest providers of professionally led at-home care for seniors, announced today that it has appointed Richard (Rick) Slager to its Board of Directors. Slager will focus on seeking new opportunities for LivHOME to grow and develop as it continues bringing top quality care to seniors living at home.

January 02, 2014

AtriCure Completes Acquisition of Estech>

AtriCure, Inc. (ATRC), a leading Atrial Fibrillation medical device provider, today announced the completion of the previously announced acquisition of Endoscopic Technologies, Inc. d/b/a Estech (“Estech”).

October 29, 2013

Vidacare Corporation to be acquired by Teleflex>

Medical device manufacturer Vidacare Corporation of San Antonio, Texas has entered into a merger agreement to be acquired by Teleflex Incorporated (NYSE: TFX) for $262.5 million plus Vidacare's net cash.

July 06, 2013

SupplyPro Announces Chief Revenue Officer and Customer Relationship Management Department>

SupplyPro announces the promotion of Stan Sigman to EVP, Chief Revenue Officer and the creation of a global Customer Relationship Management Department including the promotion of Cari Palmer to VP, Chief Customer Relationship Management Officer (CCRMO).

May 09, 2013

SYNAGEVA BIOPHARMA™ ANNOUNCES ONE YEAR OF TREATMENT DATA WITH SEBELIPASE ALFA IN LATE ONSET LAL DEFICIENCY>

Synageva BioPharma Corp. (Synageva) (NASDAQ:GEVA), today reported 12-month results from an ongoing extension study with sebelipase alfa in adults with late onset Lysosomal Acid Lipase (LAL) Deficiency. The data will be presented today by Reena Sharma, M.D., Consultant, Adult Inherited Metabolic Diseases, Salford Royal Hospital, U.K., during an oral presentation at the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) annual meeting being held in London, U.K., May 8-11, 2013.

April 30, 2013

Vidacare Corporation Expands Sales Force by Nearly 30 Percent to Support International Commercialization>

Vidacare Corporation has increased its sales force by approximately 30 percent to support international commercialization of the company’s products directly through to the end user.  The company has hired over 20 sales professionals to represent Vidacare product systems, including the   EZ-IO Intraosseous Vascular Access System and the OnControl Bone Marrow and Bone Access Systems, in targeted international markets.

March 26, 2013

Vidacare Corporation Launches iPhone App to Assist Health Care Professionals With Intraosseous Vascular Access>

Vidacare Corporation has launched a free point-of-care app for health care professionals to answer clinical and training questions related to its EZ-IO® Intraosseous Vascular Access System. The app is now available for download at the Apple iTunes Store and features interactive guides, videos and instructions on using the EZ-IO to obtain intraosseous vascular access.

 

March 19, 2013

Vidacare’s EZ-IO Intraosseous Vascular Access System Featured on National Geographic Channel’s Inside Combat Rescue>

The EZ-IO® Intraosseous Vascular Access System by San Antonio-based Vidacare Corporation was featured in the premiere of the National Geographic Channel’s six-part documentary miniseries Inside Combat Rescue on February 18.

February 14, 2013

Vidacare Corporation Expands Management Team with Three Hires and One Promotion>

Vidacare Corporation has expanded its management team with the hiring of three executives and the promotion of a fourth.

February 11, 2013

SYNAGEVA BIOPHARMA™ INITIATES DOSING IN PHASE 3 TRIAL OF SEBELIPASE ALFA>

Synageva BioPharma Corp. (Synageva) (NASDAQ:GEVA), a clinical stage biopharmaceutical company developing therapeutic products for rare diseases, today announced that the first patient initiated treatment in the ARISE trial (Acid Lipase Replacement Investigating Safety and Efficacy), a global, Phase 3, randomized, double-blind, placebo-controlled study of sebelipase alfa in children and adults with late onset lysosomal acid lipase deficiency (LAL Deficiency).
 

February 06, 2013

SYNAGEVA BIOPHARMA™ TO PRESENT AT THE LEERINK SWANN GLOBAL HEALTHCARE CONFERENCE 2013>

Synageva BioPharma Corp. (“Synageva”) (NASDAQ:GEVA), a clinical stage biopharmaceutical company developing therapeutic products for rare disorders, today announced its presentation at the upcoming Leerink Swann Global Healthcare Conference 2013. Mark Goldberg, MD, Senior Vice President, Medical and Regulatory Affairs, is scheduled to present on Wednesday, February 13, 2013, at 9:00 AM EST.

January 09, 2013

SYNAGEVA BIOPHARMA ANNOUNCES CLOSING OF PUBLIC OFFERING AND EXERCISE OF OPTION TO PURCHASE ADDITIONAL SHARES>

LEXINGTON, Mass., January 9, 2013 -- Synageva BioPharma Corp. (“Synageva”) (NASDAQ:GEVA), a clinical stage biopharmaceutical company developing therapeutic products for rare disorders, today announced the closing of a $118 million underwritten public offering of 2,472,500 shares of common stock, including 322,500 shares of common stock which were issued pursuant to the exercise of the underwriters’ option to purchase additional shares, at a price of $47.53 per share.

November 28, 2012

LivHOME CareMonitor™ Remote Care Service Begins Nationwide Rollout>

LOS ANGELES--(BUSINESS WIRE)-- LivHOME CareMonitor™ (www.livhomecaremonitor.com), a remote care service first announced in March, is beginning to roll out nationwide where LivHOME services are offered. It is currently available in Los Angeles, Walnut Creek and Riverside, Calif., and will continue to be rolled out to additional markets in late 2012 and early 2013. LivHOME CareMonitor™ is provided by LivHOME, Inc., one of the nation’s largest providers of professionally led at-home care for seniors.

November 10, 2012

SYNAGEVA BIOPHARMATM ANNOUNCES SIX-MONTH DATA FROM EXTENSION STUDY OF SBC-102>

 

Synageva BioPharma Corp. (“Synageva”) (NASDAQ:GEVA), a clinical stage biopharmaceutical company developing therapeutic products for rare diseases, today announced six month results from an ongoing extension study of sebelipase alfa in adults with late onset Lysosomal Acid Lipase (LAL) Deficiency at the American Association for the Study of Liver Diseases (AASLD) annual meeting being held in Boston, MA, November 9-13, 2012. 

October 16, 2012

Wall Street Journal Recognizes Vidacare Corporation for Second Time>

The Wall Street Journal announced the winners of its 2012 Technology Innovation Awards today, and for the second time, Vidacare Corporation has been recognized for its ground-breaking technology. Vidacare’s OnControl Bone Marrow System is the overall Bronze winner in this year’s Technology Innovation Awards and the winner of the Medical Devices category. Vidacare’s EZ-IO Intraosseous Infusion System won the overall Gold Technology Innovation of the Year award from the same program in 2008.
 

October 02, 2012

Vidacare Corporation’s OnControl Bone Access System Receives Expanded Indication from FDA>

On the heels of a recent expanded FDA indication to allow for “bone biopsy of the vertebral body and bone lesions,” Vidacare Corporation’s OnControl Bone Access System has developed a new extension of its technology platform.  The OnControl Bone Access System Coaxial Biopsy Tray for powered bone biopsy provides a tool for clinicians to access hard bones and perform biopsies of bone lesions using the company's innovative power-driver and specially engineered needle.

 

September 10, 2012

Exagen Completes $5.3M Financing to Develop New Diagnostics Products>

 


Exagen Diagnostics Inc . said it raised $5.3 million to finance market expansion and development of near-term pipeline products. Tullis Health Investors led the round. Other investors include Cottonwood Technology Fund, Epic Ventures , Mesa Verde Venture Partners and Sun Mountain Capital. 

 

September 10, 2012

SupplyPro Unveils New Refrigerated and Tablet-Based Vending Applications at IMTS 2012>

 

SupplyPro, the premier provider of Point-of-Use (POU) inventory management solutions, today announced the release of two new devices, the SupplyChiller and the SupplyPad.